A wearable cardioverter defibrillator is a
lightweight, easy to wear device worn by patients who are at a high
risk of a sudden cardiac arrest (SCA). A wearable cardioverter
defibrillator is an external device that mainly consist of two
components, garment and monitor. The garment is worn under the clothing
as a vest to continuously to monitor the heart and on detection of an
arrhythmia, it releases a shock to restore heart’s normal rhythm. The
monitor is worn around the shoulder using a shoulder strap or around the
waist. It records the intensity of the arrhythmia. This whole process
happens within a minute, as SCAs are unpredictable and need to be
treated via a shock treatment to save victim’s life. A wearable
cardioverter defibrillator is an alternative treatment method used to
prevent SCAs in non-pacemaker-dependent patients who are awaiting an
implant of a cardioverter defibrillator.
According to the World Health
Organization (WHO), cardiovascular diseases are a leading cause of
mortality globally. These diseases account for 31% of total global
mortality. According to the Sudden Cardiac Arrest Association, in the
U.S., more than 325,000 people succumb to SCA each year and among those
the survival rate is only 10%. According to the European Resuscitation
Council, SCAs cause approximately 20% of all deaths in Europe. As per
statistical projection of the United Nations (UN), the global number of
people over the age of 60 years is projected to increase from 901
million in 2015 to 1.4 billion by 2030.
Cardiac arrest is a public health issue,
which has a severe impact on the wellbeing of human health. Prevalence
of sudden cardiac arrest is directly proportional to the increasing
population, worldwide. Rapid growth in the global geriatric population
and rise in the number of sudden cardiac arrest cases are driving the
wearable cardioverter defibrillators market. Increasing per capita
income of people, rising awareness about cardiac diseases and cardiac
arrests are fuelling the wearable cardioverter defibrillators market in
developing countries. Technological advancements in wearable
cardioverter defibrillator devices, such as reduction in the noise of
electrodes, improvements in signal detection, weight and size reduction
of the device to make it more comfortable for the patient, is another
key factor boosting the wearable cardioverter defibrillators market.
However, less awareness about the wearable cardioverter defibrillator
device in developing countries and device lacking potential to detect
atrial arrhythmia signals are key restrains of the market.
The global wearable cardioverter
defibrillators market can be segmented based on application, end-user,
and region. In terms of application, the market can be segregated into
congenital heart diseases, inherited arrhythmias, and peripartum
cardiomyopathy. Based on end-user, the wearable cardioverter
defibrillators market can be divided into clinics, hospitals, and home
care settings, and others.
In terms of region, the global wearable
cardioverter defibrillators market can be categorized into North
America, Europe, Latin America, Asia Pacific, and Middle East &
Africa. North America accounts for a dominant share in the global
wearable cardioverter defibrillators market owing to the increase in
awareness among the people regarding sudden cardiac arrests and wearable
cardioverter defibrillator devices. Europe constitutes a large share of
the market due to technological advancements and rise in the number of
cardiac arrest and SCA incidences in the region. The market in Asia
Pacific is expanding at a rapid pace owing to the increase in government
support, rise in health care expenditure, and surge in per capita
income. Increasing demand for wearable cardioverter defibrillator
devices in Asia Pacific due to Rise in awareness about these devices,
government support, rise in per capita income are some of the factors
likely to fuels the market in the region.
Prominent players in the global wearable
cardioverter defibrillators market include Medtronic, Cardiac Science,
LivaNova, Boston Scientific Corporation, St. Jude Medical LLC,
Koninklijke Philips N.V., Nihon Kohden Corporation, Defibtech LLC, and
Physio-Control Inc.
No comments:
Post a Comment